학술논문

Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic
Document Type
article
Author
Glasbey, James CNepogodiev, DmitriSimoes, Joana FFOmar, Omar MVenn, Mary LEvans, Jonathan PFutaba, KaoriKnowles, Charles HMinaya‐Bravo, AnaMohan, HelenChand, ManishPockney, PeterDi Saverio, SalomoneSmart, NeilVallance, AbigailVimalachandran, DaleWilkin, Richard JWSiaw‐Acheampong, KwabenaBenson, Ruth ABywater, EdwardChaudhry, DaoudDawson, Brett EGujjuri, Rohan RHeritage, EmilyJones, Conor SKamarajah, Sivesh KKhatri, ChetanKhaw, Rachel AKeatley, James MKnight, AndrewLawday, SamuelMann, Harvinder SMarson, Ella JMcLean, Kenneth AMckay, Siobhan CMills, Emily CPellino, GianlucaPicciochi, MariaTaylor, Elliott HTiwari, AbhinavTrout, Isobel MSmart, Neil JGallo, GaetanoMoug, SusanPata, FrancescoVimalchandran, DaleAbbott, Tom EFAbukhalaf, SadiAdamina, MichelAdemuyiwa, Adesoji OAgarwal, ArnavAkkulak, MuratAlameer, EhabAlderson, DerekAlakaloko, FelixAlbertsmeiers, MarkusAlser, OsaidAlshaar, MuhammadAlshryda, SattarArnaud, Alexis PMagne Augestad, KnutAyasra, FarisAzevedo, JoséBankhead‐Kendall, Brittany KBarlow, EmmaBeard, DavidBlanco‐Colino, RuthBrar, AmanpreetBreen, Kerry ABretherton, ChrisLima Buarque, IgorBurke, JoshuaCaruana, Edward JChaar, MohammadChakrabortee, SohiniChristensen, PeterCox, DanielCukier, MoisesCunha, Miguel FDavidson, Giana HDesai, AnantDrake, Thomas MEdwards, John GElhadi, MuhammedEmile, SamehFarik, ShebaniFiore, MarcoEdward Fitzgerald, JFord, SamuelGarmanova, Tatiana
Source
Colorectal Disease. 23(3)
Subject
Digestive Diseases
Patient Safety
Pneumonia
Emerging Infectious Diseases
Clinical Research
Prevention
Cancer
Colo-Rectal Cancer
Lung
6.4 Surgery
Evaluation of treatments and therapeutic interventions
Good Health and Well Being
COVIDSurg Collaborative
COVID-19
SARS-CoV-2
cancer
colon cancer
pandemic
rectal cancer
surgery
surgical oncology
Clinical Sciences
Surgery
Language
Abstract
AimThis study aimed to describe the change in surgical practice and the impact of SARS-CoV-2 on mortality after surgical resection of colorectal cancer during the initial phases of the SARS-CoV-2 pandemic.MethodThis was an international cohort study of patients undergoing elective resection of colon or rectal cancer without preoperative suspicion of SARS-CoV-2. Centres entered data from their first recorded case of COVID-19 until 19 April 2020. The primary outcome was 30-day mortality. Secondary outcomes included anastomotic leak, postoperative SARS-CoV-2 and a comparison with prepandemic European Society of Coloproctology cohort data.ResultsFrom 2073 patients in 40 countries, 1.3% (27/2073) had a defunctioning stoma and 3.0% (63/2073) had an end stoma instead of an anastomosis only. Thirty-day mortality was 1.8% (38/2073), the incidence of postoperative SARS-CoV-2 was 3.8% (78/2073) and the anastomotic leak rate was 4.9% (86/1738). Mortality was lowest in patients without a leak or SARS-CoV-2 (14/1601, 0.9%) and highest in patients with both a leak and SARS-CoV-2 (5/13, 38.5%). Mortality was independently associated with anastomotic leak (adjusted odds ratio 6.01, 95% confidence interval 2.58-14.06), postoperative SARS-CoV-2 (16.90, 7.86-36.38), male sex (2.46, 1.01-5.93), age >70 years (2.87, 1.32-6.20) and advanced cancer stage (3.43, 1.16-10.21). Compared with prepandemic data, there were fewer anastomotic leaks (4.9% versus 7.7%) and an overall shorter length of stay (6 versus 7 days) but higher mortality (1.7% versus 1.1%).ConclusionSurgeons need to further mitigate against both SARS-CoV-2 and anastomotic leak when offering surgery during current and future COVID-19 waves based on patient, operative and organizational risks.